Annual Total Liabilities
$50.70 M
+$25.16 M+98.50%
December 31, 2023
Summary
- As of February 12, 2025, BLRX annual total liabilities is $50.70 million, with the most recent change of +$25.16 million (+98.50%) on December 31, 2023.
- During the last 3 years, BLRX annual total liabilities has risen by +$25.44 million (+100.72%).
- BLRX annual total liabilities is now at all-time high.
Performance
BLRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$44.24 M
-$6.38 M-12.60%
September 1, 2024
Summary
- As of February 12, 2025, BLRX quarterly total liabilities is $44.24 million, with the most recent change of -$6.38 million (-12.60%) on September 1, 2024.
- Over the past year, BLRX quarterly total liabilities has stayed the same.
- BLRX quarterly total liabilities is now -12.75% below its all-time high of $50.70 million, reached on December 31, 2023.
Performance
BLRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BLRX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +98.5% | 0.0% |
| 3 y3 years | +100.7% | 0.0% |
| 5 y5 years | +240.0% | 0.0% |
BLRX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +281.1% | -12.8% | +292.5% |
| 5 y | 5-year | at high | +281.1% | -12.8% | +292.5% |
| alltime | all time | at high | +1273.3% | -12.8% | +1405.2% |
BioLineRx Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.24 M(-12.6%) |
| Jun 2024 | - | $50.62 M(+31.3%) |
| Mar 2024 | - | $38.54 M(-24.0%) |
| Dec 2023 | $50.70 M(+98.5%) | $50.70 M(+27.6%) |
| Sep 2023 | - | $39.72 M(+4.9%) |
| Jun 2023 | - | $37.88 M(+28.3%) |
| Mar 2023 | - | $29.53 M(+15.6%) |
| Dec 2022 | $25.54 M(+92.0%) | $25.54 M(-2.3%) |
| Sep 2022 | - | $26.15 M(+132.0%) |
| Jun 2022 | - | $11.27 M(-0.8%) |
| Mar 2022 | - | $11.36 M(-14.6%) |
| Dec 2021 | $13.30 M(-47.3%) | $13.30 M(-16.9%) |
| Sep 2021 | - | $16.00 M(-8.2%) |
| Jun 2021 | - | $17.44 M(-8.0%) |
| Mar 2021 | - | $18.95 M(-25.0%) |
| Dec 2020 | $25.26 M(+25.1%) | $25.26 M(+19.0%) |
| Sep 2020 | - | $21.23 M(-10.6%) |
| Jun 2020 | - | $23.76 M(+27.3%) |
| Mar 2020 | - | $18.66 M(-7.5%) |
| Dec 2019 | $20.19 M(+35.4%) | $20.19 M(+12.0%) |
| Sep 2019 | - | $18.03 M(-10.7%) |
| Jun 2019 | - | $20.18 M(-7.0%) |
| Mar 2019 | - | $21.71 M(+45.6%) |
| Dec 2018 | $14.91 M(+84.5%) | $14.91 M(+156.4%) |
| Sep 2018 | - | $5.82 M(-3.5%) |
| Jun 2018 | - | $6.03 M(-14.5%) |
| Mar 2018 | - | $7.05 M(-12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $8.08 M(+106.6%) | $8.08 M(+13.8%) |
| Sep 2017 | - | $7.10 M(+26.4%) |
| Jun 2017 | - | $5.62 M(+4.0%) |
| Mar 2017 | - | $5.40 M(+38.1%) |
| Dec 2016 | $3.91 M(+6.0%) | $3.91 M(+6.7%) |
| Sep 2016 | - | $3.67 M(+17.7%) |
| Jun 2016 | - | $3.12 M(+6.0%) |
| Mar 2016 | - | $2.94 M(-20.4%) |
| Dec 2015 | $3.69 M(-16.2%) | $3.69 M(-15.3%) |
| Sep 2015 | - | $4.36 M(-33.3%) |
| Jun 2015 | - | $6.54 M(+15.0%) |
| Mar 2015 | - | $5.68 M(+29.0%) |
| Dec 2014 | $4.41 M(-46.9%) | $4.41 M(+7.6%) |
| Sep 2014 | - | $4.09 M(-28.8%) |
| Jun 2014 | - | $5.75 M(-14.8%) |
| Mar 2014 | - | $6.75 M(-18.6%) |
| Dec 2013 | $8.29 M(-11.2%) | $8.29 M(+2.9%) |
| Sep 2013 | - | $8.06 M(+5.2%) |
| Jun 2013 | - | $7.66 M(-26.3%) |
| Mar 2013 | - | $10.40 M(+11.4%) |
| Dec 2012 | $9.34 M(+37.2%) | $9.34 M(-5.7%) |
| Sep 2012 | - | $9.90 M(+5.7%) |
| Jun 2012 | - | $9.37 M(-16.3%) |
| Mar 2012 | - | $11.19 M(+64.5%) |
| Dec 2011 | $6.81 M | $6.81 M(+1.9%) |
| Sep 2011 | - | $6.68 M(-3.7%) |
| Jun 2011 | - | $6.94 M(+7.0%) |
| Mar 2011 | - | $6.49 M |
FAQ
- What is BioLineRx annual total liabilities?
- What is the all time high annual total liabilities for BioLineRx?
- What is BioLineRx annual total liabilities year-on-year change?
- What is BioLineRx quarterly total liabilities?
- What is the all time high quarterly total liabilities for BioLineRx?
- What is BioLineRx quarterly total liabilities year-on-year change?
What is BioLineRx annual total liabilities?
The current annual total liabilities of BLRX is $50.70 M
What is the all time high annual total liabilities for BioLineRx?
BioLineRx all-time high annual total liabilities is $50.70 M
What is BioLineRx annual total liabilities year-on-year change?
Over the past year, BLRX annual total liabilities has changed by +$25.16 M (+98.50%)
What is BioLineRx quarterly total liabilities?
The current quarterly total liabilities of BLRX is $44.24 M
What is the all time high quarterly total liabilities for BioLineRx?
BioLineRx all-time high quarterly total liabilities is $50.70 M
What is BioLineRx quarterly total liabilities year-on-year change?
Over the past year, BLRX quarterly total liabilities has changed by $0.00 (0.00%)